(603976)"CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO., LTD."Report for Q3 2026
Filed with SSE · Stock code 603976 · · 12 pages · Chinese
Summary by 6ix AI
The report confirms that the financial data has not been audited and emphasizes the accuracy and completeness of the information provided. Key financial highlights include significant increases in total revenue and net profit compared to the same period last year. The report also outlines the company's total assets and shareholders' equity at the end of the reporting period. Overall, this filing serves to inform shareholders about the company's financial status and operational results for the quarter.
Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries
Chongqing Zhengchuan Pharmaceutical Packaging Co. Ltd. on 6ix
Earlier from Chongqing Zhengchuan Pharmaceutical Packaging
- Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Chongqing Jurisdiction and Semi-annual Performance Briefing
- Announcement on Convening the 2026 Semi-annual Performance Briefing
- Semi-annual Report for 2026
- Announcement on Shareholding Reduction Plan for Directors and Senior Management
- Announcement by China Lianhe Credit Rating Co., Ltd. on Termination of the Issuer Credit Rating of CHONGQING ZHENGCHUAN PHARMACEUTICAL PACKAGING CO., LTD. and the Credit Rating of "ZHENGCHUAN Convertible Bonds"
Later from Chongqing Zhengchuan Pharmaceutical Packaging
All Chongqing Zhengchuan Pharmaceutical Packaging news releasesFollow Chongqing Zhengchuan Pharmaceutical Packaging into a list and get an email when it puts out news.
Follow Chongqing Zhengchuan Pharmaceutical Packaging